Long-term effects of medication for opioid use disorder in children

Jamie Cox1, Nancy Reid, Laura Lander

  • 1Jamie Cox practices in emergency medicine at WVU Medicine in Buckhannon, W.Va. Nancy Reid is an associate professor in the PA program at the University of Lynchburg in Lynchburg, Va. Laura Lander is an associate professor and section chief of social work at WVU Health Sciences University in Morgantown, W.Va. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Insights

Opioid maintenance therapy during pregnancy can lead to neonatal abstinence syndrome (NAS) in infants. This can impact neurocognitive development, affecting long-term outcomes like education and employment.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Public Health

Background:

  • Opioid maintenance therapy (OMT) in pregnant individuals can lead to Neonatal Abstinence Syndrome (NAS) in newborns.
  • Infants with NAS face significant risks for impaired neurocognitive development.
  • These developmental deficits can have lasting consequences into adulthood, including academic and socioeconomic challenges.

Purpose of the Study:

  • To discuss the neurocognitive development consequences of medicated opioid use disorder in infants and children.
  • To explore methods to support the neurocognitive potential of these children into adulthood.

Main Methods:

  • Literature review on neurocognitive outcomes in children exposed to OMT in utero.
  • Discussion of developmental trajectories and potential interventions.

Main Results:

  • Children exposed to OMT in utero and diagnosed with NAS often exhibit neurocognitive deficits.
  • These deficits can manifest as difficulties in school performance, increased risk of unemployment, and higher likelihood of criminal activity.
  • Early and consistent support may mitigate some of these long-term negative outcomes.

Conclusions:

  • Neonatal Abstinence Syndrome resulting from maternal opioid maintenance therapy poses a serious risk to neurocognitive development.
  • Intervention strategies are crucial to help affected children achieve their full potential.
  • Addressing these neurodevelopmental challenges is essential for improving long-term life outcomes.

Related Concept Videos

Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
403
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
234
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
464
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
179
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
851